Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation
10.1007/s12640-018-9991-2 · doi-reference
Cinnamaldehyde (TRPA1 agonist) protected against olanzapine-induced metabolic alterations in mice: involvement of hypothalamic energy sensing, appetite regulation and inflammatory aberrations
10.1016/j.psyneuen.2021.105525 · doi-reference
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons
10.1523/jneurosci.19-11-04544.1999 · doi-reference
Anandamide and 2-arachidonoylglycerol: Pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids
10.1007/s12035-012-8299-0 · doi-reference
CB1 cannabinoid receptor‐mediated modulation of food intake in mice
10.1038/sj.bjp.0706157 · doi-reference
Anxiety associated with palatable food withdrawal is reversed by the selective FAAH inhibitor PF‐3845: A regional analysis of the contribution of endocannabinoid signaling machinery
10.1002/eat.23917 · doi-reference
Diet‐Induced Obesity in Cannabinoid‐2 Receptor Knockout Mice and Cannabinoid Receptor 1/2 Double‐Knockout Mice
10.1002/oby.22403 · doi-reference
Maternal high-fat diet induces sex-specific endocannabinoid system changes in newborn rats and programs adiposity, energy expenditure and food preference in adulthood
10.1016/j.jnutbio.2017.09.019 · doi-reference
Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice
10.1371/journal.pone.0140592 · doi-reference
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats
10.1016/j.nut.2014.06.008 · doi-reference
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands
10.1002/syn.20714 · doi-reference
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
10.1007/s00125-010-1894-6 · doi-reference
Effects of the CB1 receptor antagonists AM6545 and AM4113 on insulin resistance in a high-fructose high-salt rat model of metabolic syndrome
10.3390/medicina56110573 · doi-reference
Low-grade inflammation, obesity, and diabetes
10.1007/s13679-014-0124-9 · doi-reference
Therapeutical potential of CB2 receptors in immune-related diseases
10.2174/1874467207666140219122337 · doi-reference
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice
10.1053/j.gastro.2012.01.032 · doi-reference
Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption
10.1196/annals.1432.035 · doi-reference
Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats
10.1016/s0006-8993(02)04274-9 · doi-reference
Ghrelin recruits the endocannabinoid system to modulate food reward
10.1523/jneurosci.1620-24.2024 · doi-reference
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system
10.1371/journal.pone.0001797 · doi-reference
Endocannabinoids in body weight control
10.3390/ph11020055 · doi-reference
The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release, The
10.1096/fj.13-232918 · doi-reference
Ghrelin as a prominent endocrine factor in stress-induced obesity
10.1080/1028415x.2020.1863740 · doi-reference
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance
10.1016/j.cmet.2012.07.002 · doi-reference
New insights of SF1 neurons in hypothalamic regulation of obesity and diabetes
10.3390/ijms22126186 · doi-reference
Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
10.1016/j.amjmed.2007.06.007 · doi-reference
Overactivation of the endocannabinoid system alters the antilipolytic action of insulin in mouse adipose tissue
10.1152/ajpendo.00374.2016 · doi-reference
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
10.1016/j.molmet.2014.07.004 · doi-reference
Neuropeptide y receptor selective ligands in the treatment of obesity
10.1210/er.2007-0003 · doi-reference
60 years of POMC: regulation of feeding and energy homeostasis by α-MSH
10.1530/jme-16-0014 · doi-reference
High fat diet increases circulating endocannabinoids accompanied by increased synthesis enzymes in adipose tissue
10.3389/fphys.2018.01913 · doi-reference
The endocannabinoid system is modulated in reward and homeostatic brain regions following diet-induced obesity in rats: a cluster analysis approach
10.1007/s00394-021-02613-0 · doi-reference
Obesity affects the microbiota–gut–brain axis and the regulation thereof by endocannabinoids and related mediators
10.3390/ijms21051554 · doi-reference
Leptin as a key regulator of the adipose organ
10.1007/s11154-021-09687-5 · doi-reference
Endocannabinoids and energy homeostasis: an update
10.1002/biof.1168 · doi-reference
Food for thought: reward mechanisms and hedonic overeating in obesity
10.1007/s13679-017-0280-9 · doi-reference
Targeting the endocannabinoid CB1 receptor to treat body weight disorders: a preclinical and clinical review of the therapeutic potential of past and present CB1 drugs
10.3390/biom10060855 · doi-reference
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
10.1038/sj.ijo.0802583 · doi-reference
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
10.1152/ajpregu.00545.2002 · doi-reference
Leptin, the brain and energy homeostasis: From an apparently simple to a highly complex neuronal system
10.1007/s11154-021-09636-2 · doi-reference
